Excerpt of services by la volta statistics |
||
|
2010
|
ESTIMATE: Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland (for an international pharmaceutical company based in Switzerland, ongoing). | |
|
2010
|
Attitude of Swiss physicians towards opioid-induced constipation: a national survey for an international pharmaceutical company based in Switzerland. | |
|
2009
|
Automation of data preparation and layout for 360° feedback reports for an international business consultant company. | |
|
2009
|
START: Swiss Taxotere Alopecia Prevention Trial for an international pharmaceutical company based in Switzerland.(ongoing). |
|
|
2009 - 2010
|
SWIVTER: the Swiss Venous Thromboembolism Registry. Web based data collection in a joint project by an international pharmaceutical company in Switzerland and Swiss hospitals | |
|
2008 - 2009
|
Phase IV trial for the assessment of patient and physician satisfaction with self-management of diabetes for an international pharmaceutical company based in Switzerland. | |
|
2008
|
Analyses of the role of store environmental stimulation for a market research institution based in Switzerland | |
|
2008
|
Matched case control study evaluating tar impregnation for smoking patients. Swiss hospitals. | |
|
2008 - 2009
|
Statistical analysis of a phase IV trial for blood pressure reduction treatments for an international pharmaceutical company based Switzerland. | |
|
2007 - 2008
|
VTE prophylaxis in high-risk surgical patients at discharge. Web based data collection in a joint project by an international pharmaceutical company in Switzerland and Swiss hospitals. | |
|
2006 - 2007
|
Automation of data preparation and layout for 360° feedback reports for an international business consultant company. | |
|
2006 - 2010
|
Randomised, controlled clinical trial (Phase III) for substitution of opiate dependency (ongoing). | |
| 2006 - 2007
|
Statistical analysis of a phase IV trial for blood pressure reduction treatments for an international pharmaceutical company based Switzerland. | |
|
2006 - 2008 |
Swiss Venous Thromboembolism Prevention Registry. Web based data collection in a joint project by an international pharmaceutical company in Switzerland and Swiss hospitals. | |
| 2005 - 2007
|
Statistical analysis of treatment for chronic inflammatory rheumatologic diseases with advanced generation biphosphonates. Phase II trial in Swiss hospital. | |
| 2006 |
Data analysis of questionnaires on employee satisfaction in a German government department. | |
| 2006 |
Analyses for long-term outcome after percutaneous coronary intervention for acute myocardial infarction (Swiss hospital). | |
| 2006 |
Probit analyses for quality standards of blood (Swiss organisations for blood donation). | |
| 2005 - 2006
|
Statistical efficacy analysis of treatment with retarded released opioides in patients with acute pain. Phase IV trial by a Swiss based international pharmaceutical company. | |
| 2005 |
Swiss Company, market research. Consumer Segmentation. Cluster analysis of more than 500'000 client cases to identify and define customer segments. | |
| 2005 |
Swiss bank, market research. Conjoint analyses for retention in a banks staff segment. | |
| 2005 |
International pharmaceutical company in Switzerland: statistical analyses of time dependent changes in dosages for long time morphine treatments. | |
| 2005 |
International pharmaceutical company in Switzerland: Statistical analysis of a Phase IV trial for pain control in patients with pemanent pain (Trial II). | |
| 2002 - 2005 |
International pharmaceutical company, oncology & infectious diseases, Switzerland. Open randomized, comparative safety, tolerance and efficacy phase IV study of two antibiotics with the goal of testing for equivalence in efficacy. | |
| 2002 - 2006 |
International pharmaceutical company in Switzerland: A randomized prospective open label equivalence comparison of efficacy, safety, and costs in two different treatments of patients undergoing percuteaneous coronary interventions. | |
| 1998 - 2005 |
Swiss bank, market research. Panel study with 20'000/year randomly selected national banking users. Questionnaire of 90 questions to observe client loyalty and satisfaction with the major Swiss banks. | |
| 2004 |
International pharmaceutical company: Meta-analyses for hormonal effects of in the improvements of sleep. | |
| 2004 |
International pharmaceutical company in Switzerland: Statistical analysis of a Phase IV trial for pain control in patients with pemanent pain (Trial I). | |
| 2004 |
International pharmaceutical company: Statistical expert reports for legal requests. | |
| 2003 - 2004 |
International pharmaceutical company in Switzerland: Multi-centre phase IV study to establish efficacy and safety in an opiate based treatment in patients for patients with intense chronic pain in Switzerland. | |
| 2002 - 2004 |
Swiss pharmaceutical company. Open single-centre phase III study to evaluate the safety and immunogenicity of different doses of a Hepatitis A vaccine with children of four different age groups in Thailand. | |
| 2001 - 2004 |
International pharmaceutical company in Switzerland. Multi-centre phase II study to establish efficacy and safety for a combined treatment in hormone-refractory cancer in Swiss hospitals. | |
| 2001 - 2003 |
Swiss pharmaceutical company. Open randomized clinical phase III trial to compare the safety und immunogenicity of vaccine combinations against mumps, measles, rubella (MMR) for children in Berlin. | |